EyePoint Pharmaceuticals Inc (EYPT)
19.74
-0.20
(-1.00%)
USD |
NASDAQ |
May 03, 16:00
13.75
-5.99
(-30.34%)
After-Hours: 07:48
EyePoint Pharmaceuticals 1 Year Total Returns (Daily): 149.9% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 149.9% |
May 02, 2024 | 207.2% |
May 01, 2024 | 171.7% |
April 30, 2024 | 180.3% |
April 29, 2024 | 180.7% |
April 26, 2024 | 118.5% |
April 25, 2024 | 134.9% |
April 24, 2024 | 112.2% |
April 23, 2024 | 95.22% |
April 22, 2024 | 88.33% |
April 19, 2024 | 227.5% |
April 18, 2024 | 255.7% |
April 17, 2024 | 331.8% |
April 16, 2024 | 404.4% |
April 15, 2024 | 391.5% |
April 12, 2024 | 570.1% |
April 11, 2024 | 573.2% |
April 10, 2024 | 553.9% |
April 09, 2024 | 560.4% |
April 08, 2024 | 535.9% |
April 05, 2024 | 570.4% |
April 04, 2024 | 521.0% |
April 03, 2024 | 558.7% |
April 02, 2024 | 589.8% |
April 01, 2024 | 589.5% |
Date | Value |
---|---|
March 28, 2024 | 625.3% |
March 27, 2024 | 635.3% |
March 26, 2024 | 804.8% |
March 25, 2024 | 851.3% |
March 22, 2024 | 831.4% |
March 21, 2024 | 820.2% |
March 20, 2024 | 860.9% |
March 19, 2024 | 840.4% |
March 18, 2024 | 806.4% |
March 15, 2024 | 798.7% |
March 14, 2024 | 762.7% |
March 13, 2024 | 759.5% |
March 12, 2024 | 842.6% |
March 11, 2024 | 845.0% |
March 08, 2024 | 763.7% |
March 07, 2024 | 706.1% |
March 06, 2024 | 694.4% |
March 05, 2024 | 684.4% |
March 04, 2024 | 694.8% |
March 01, 2024 | 783.3% |
February 29, 2024 | 714.7% |
February 28, 2024 | 728.7% |
February 27, 2024 | 750.7% |
February 26, 2024 | 709.5% |
February 23, 2024 | 658.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.03%
Minimum
Nov 03 2020
860.9%
Maximum
Mar 20 2024
38.28%
Average
-17.71%
Median
Jun 17 2022
1 Year Total Returns (Daily) Benchmarks
INVO Bioscience Inc | -87.01% |
Bio-Path Holdings Inc | -90.81% |
Ocular Therapeutix Inc | -0.32% |
Aileron Therapeutics Inc | 176.5% |
Apellis Pharmaceuticals Inc | -44.18% |